Get started
Author

Srikanth Muppidi

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
2017 · James F Howard, Kimiaki Utsugisawa, et al. · The Lancet Neurology · 845
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
2021 · James F Howard, Vera Bril, et al. · The Lancet Neurology · 739
Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis
2019 · Srikanth Muppidi, Kimiaki Utsugisawa, et al. · Muscle & Nerve · 262
PDF
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial
2019 · Gil I Wolfe, Henry J Kaminski, et al. · The Lancet Neurology · 231
A Genome-Wide Association Study of Myasthenia Gravis
2015 · Alan E. Renton, Hannah A. Pliner, et al. · JAMA Neurology · 206
MG‐ADL: Still a relevant outcome measure
2011 · Srikanth Muppidi, Gil I. Wolfe, et al. · Muscle & Nerve · 173
A case report of postural tachycardia syndrome after COVID-19
2020 · Mitchell G. Miglis, Thomas Prieto, et al. · Clinical Autonomic Research · 165
PDF
Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic
2020 · Saiju Jacob, Srikanth Muppidi, et al. · Journal of the Neurological Sciences · 155
PDF
Characterization of autonomic symptom burden in long COVID: A global survey of 2,314 adults
2022 · Nicholas W. Larsen, Lauren E. Stiles, et al. · Frontiers in Neurology · 150
PDF
Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study
2022 · Ruth Chia, Sara Saez-Atienzar, et al. · Proceedings of the National Academy of Sciences · 127
COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)
2020 · Srikanth Muppidi, Jeffrey T Guptill, et al. · The Lancet Neurology · 122
PDF
Utilization of MG‐ADL in myasthenia gravis clinical research and care
2022 · Srikanth Muppidi, Nicholas J. Silvestri, et al. · Muscle & Nerve · 108
PDF
Dynamic pupillometry as an autonomic testing tool
2013 · Srikanth Muppidi, Beverley Adams-Huet, et al. · Clinical Autonomic Research · 86
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension
2020 · Renato Mantegazza, Gil I. Wolfe, et al. · Neurology · 83
PDF
The Myasthenia Gravis‐Specific Activities of Daily Living Profile
2012 · Srikanth Muppidi · Annals of the New York Academy of Sciences · 80
Comparative effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis (PROMISE-MG): a prospective cohort study
2024 · Pushpa Narayanaswami, Donald B Sanders, et al. · The Lancet Neurology · 60
Eculizumab improves fatigue in refractory generalized myasthenia gravis
2019 · Henning Andersen, Renato Mantegazza, et al. · Quality of Life Research · 58
PDF
Patient-reported burden of myasthenia gravis: baseline results of the international prospective, observational, longitudinal real-world digital study MyRealWorld-MG
2023 · Sarah Dewilde, Glenn Philips, et al. · BMJ Open · 53
PDF
Plasma exchange for severe immune-related adverse events from checkpoint inhibitors: an early window of opportunity?
2022 · Tamiko R Katsumoto, Kalin L Wilson, et al. · Immunotherapy Advances · 51
PDF
Telemedicine visits in myasthenia gravis: Expert guidance and the Myasthenia Gravis Core Exam ( MG‐CE )
2021 · Amanda C. Guidon, Srikanth Muppidi, et al. · Muscle & Nerve · 41
Non-invasive wearables for remote monitoring of HbA1c and glucose variability: proof of concept
2021 · Brinnae Bent, Peter J Cho, et al. · BMJ Open Diabetes Research & Care · 40
PDF
Postural tachycardia in hypermobile Ehlers-Danlos syndrome: A distinct subtype?
2017 · Mitchell G. Miglis, Brittany Schultz, et al. · Autonomic Neuroscience · 38
Concomitant Immunosuppressive Therapy Use in Eculizumab-Treated Adults With Generalized Myasthenia Gravis During the REGAIN Open-Label Extension Study
2020 · Richard J. Nowak, Srikanth Muppidi, et al. · Frontiers in Neurology · 37
PDF
Safety and outcomes with efgartigimod use for acetylcholine receptor‐positive generalized myasthenia gravis in clinical practice
2023 · Nakul Katyal, Karen Halldorsdottir, et al. · Muscle & Nerve · 35
PDF
Outcome Measures in Myasthenia Gravis: Incorporation Into Clinical Practice
2017 · Srikanth Muppidi · Journal of Clinical Neuromuscular Disease · 35
Works count: 155
Citation count: 4,730
H-index: 28
I10-index: 46
Year
Topic
Type